Covaxin Approval for Kids

New Delhi:  Hyderabad-based pharma major Bharat Biotech's US partner Ocugen has sought the Emergency Use Authorisation (EUA) from the US FDA for Covaxin to be administered in children aged two to 18 years. Ocugen said that it has…